中国寄生虫学与寄生虫病杂志 ›› 1987, Vol. 5 ›› Issue (3): 194-196.

• • 上一篇    下一篇

磷酸咯萘啶与磺胺多辛、伯喹伍用在抗氯喹地区治疗恶性疟的观察

车立刚,黄开国,杨恒林,余蕾,林志良,黄荣   

  1. 云南省疟疾防治研究所
  • 出版日期:1987-08-31 发布日期:2017-01-12
  • 基金资助:
    全国疟疾专题委员会 云南省卫生厅资助

COMBINED USE OF PYRONARIDINE, SULFADOXINE AND PRIMAQUINE IN AREAS WITH CHLOROQUINE-RESISTANT FALCIPARUM MALARIA

  • Online:1987-08-31 Published:2017-01-12

摘要: 将磷酸咯萘啶1.2g与磺胺多辛1.0g.伯喹45mg伍用,在抗氯喹恶性疟流行区治疗恶性疟48例,治疗后平均退热时间32±16h,平均原虫无性体转阴时间59±20.8h.服药后48h疟原虫无性体下降率为88~100%,即时疗效与单用磷酸咯萘啶1.2g对照组相似.伍用组一个月内复燃率2.5%,服药后配子体转阴时间1~12d,并能减少配子体出现,根治效果和对配子体的作用优于单用组。三药伍用后毒副反应无明显增加,是治疗抗氯喹恶性疟的较好方案.

关键词: 磷酸咯萘啶, 恶性疟, 磺胺多辛, 疟原虫配子体, 抗氯喹, 伍用, 疟疾防治, 无性体, 云南省, 治疗后

Abstract: Fourty-eight falciparam malaria cases were treated by pyronaridine phosphate (1.2 S base) jointly with sulfadimoxine (1g) and primaquine phosphate (45 mg base) in 2 days in Mengla County, Yunnan Province, where chioroquine-resistant Plasmodium falciparum is endemic. 36 falciparum malaria cases were treated with pyronaridine (1.2 g) alone. The average defervescence time of the combined treatment group and the pyronaridine group was 32 ±16 h and 32.7±16h; the mean asexual parasite clearance time of the groups was 59±20.8 h and 64 ± 22.9 h respectively. During 1 month follow-up, the asexual parasite recrudescence irate of the 2 groups was 2.5% and 15.2%; the gametocyte-carrying rate was 50.0% (19/38) and 93.9% (31/33). No marked side effects were observed in the co-mbined therapy.